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Antimycobacterial activity of pyrimido[4,5-b]diazepine
derivatives
J.G. Bueno Sánchez1,∗, A. Garcia2, B. Insuasty2, J. Quiroga2
1 Instituto Nacional de Salud, Bogotá, Colombia
2 Grupo de Investigación de Compuestos Heterocíclicos,
Departamento de Química, Universidad de Valle, Cali,
Colombia
Background: Human tuberculosis is a contagious-
infectious disease mainly caused by Mycobacterium tuber-
culosis, which is an aerobic pathogenic bacterium that
establishes its infection usually in the lungs. About one
third of the world’s population is currently infected with
M. tuberculosis; 10% of those infected will develop clinical
disease, particularly those who also have the human immun-
odeﬁciency virus (HIV) infection. This problem is further
compounded by a dramatic increase in multidrug-resistant
strains of M. tuberculosis which demands the search
for alternative antimycobacterial drugs. In this effort,
diazepine derivatives, which showed a broad spectrum of
biological activity especially antitumoral is presented as
a promising source of new compounds-leaders. Using the
existing capacity that posses the Colombian National Insti-
tute of Health (NIH) for to develop reproducible in vitro tests
against mycobacteria species and the research trajectory
of Grupo de Investigación de Compuestos Heterocíclicos,
the aim of this study was to determine the activity against
15 Mycobacterium spp strains and clinical isolates of 12
diazepine derivatives.
Methods: The synthesis of pyrimidodiazepines by
microwave irradiation (200 ◦C, 300W) during 2-8minutes
of equimolar mixture of 2-R-4,5,6-triamino-pyrimidines and
chalcones in DMF (0.5mL) and catalytic amount of BF3.OEt2
(0.5mL. The minimum inhibitory concentration (MIC) was
determined by colorimetric broth microdilution method.
The activity was evaluated against ﬁve M. tuberculosis ATCC
strains, 5 isolates of Beijing genotype and 5 clinical isolates
of nontuberculous mycobacteria. Isoniazid and rifampicin
were used as control drugs.
Results: In total six diazepine derivatives showed mod-
erate activity at concentrations in a range between
16-32g/mL (Good activity CMI <10g/ mL), three were
active against 13 microorganisms; the rest just inhibited the
growth of M. tuberculosis strains.
Conclusion: Diazepine derivatives scaffolds over the
years have gained an ongoing interest for biological
activities as anticancer, anti-bacterial, psychotropics, anti-
convulsant, anti-viral, and herbicidal. This is the ﬁrst
report of antimycobacterial activity of diazepine compounds
developed entirely in Colombia, in addition, also includes
multidrug-resistant isolates classiﬁed in the national resis-
tance studies conducted in the Colombian National Institute
of Health (NIH).
doi:10.1016/j.ijid.2010.02.1912ts e191
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ive-year trend of antimicrobial susceptibility rates
nd daptomycin activity among Staphylococcus aureus
solates collected in Latin American medical eenters
2005-2009)
.J. biedenbach, R.N. jones, H. Sader ∗
JMI Laboratories, North Liberty, IA, USA
Background: Daptomycin is lipopeptide with a unique
echanism of action and rapid bactericidal activity against
ram-positive cocci. Daptomycin is approved for the treat-
ent of Gram-positive pathogen associated complicated
kin and skin structure infections (cSSSI) and S. aureus (SA)-
ssociated bacteremia and endocarditis and in the United
tates, Europe and some Latin American (LA) countries. The
n vitro activity of daptomycin and comparator agents was
valuated against clinical isolates of SA collected in four LA
ountries over ﬁve years.
Methods: 6,031 SA isolates were collected in 10 med-
cal centers located in Argentina (1,075), Brazil (2,637),
hile (1,345) and Mexico (974). Isolates were mainly from
loodstream (42.1%) and cSSSI (28.6%). Susceptibility (S)
as determined by the CLSI broth microdilution method
n cation-adjusted Mueller-Hinton broth supplemented to
0mg/L of calcium for daptomycin tests.
Results: The overall oxacillin resistance (MRSA) rate in LA
as 41.1% and ranged from 32.1-39.0% in Brazil and Mexico
o 51.7-51.9% in Argentina and Chile. MRSA rates increased
ontinuously from 34.7 (2005) to 48.4% (2009). Daptomycin
as highly active against SA in all LA countries with MIC50
nd MIC90 values of 0.25 and 0.5mg/ml, respectively. Over-
ll, daptomycin was highly active against MRSA (100.0%
, see table) as was vancomycin (MIC50/90, 1/1mg/ml;
00% S) and linezolid (MIC50/90, 1/2mg/ml; >99.9% S).
rythromycin resistance was higher in Chile and Mexico
46.5-54.5%) than in Argentina and Brazil (38.2-39.4%). Over-
ll constitutive clindamycin resistance was 78.8% in LA.
MP/SMX and tetracycline resistance was much higher in
razil (20.6-23.6%) compared to other countries (1.5-6.2%).
evoﬂoxacin and gentamicin resistance was highest in Chile
t 52.1% and 42.8%, respectively.
ation (no. of
SA strains)
Cumulative % inhibited at daptomycin MIC
(g/ml) of:
≤0.06 0.12 0.25 0.5 1 2
rgentina
(1,075)
0.0 2.3 62.1 98.5 100.0 -
razil (2,637) 0.1 2.1 61.1 98.4 100.0 -
hile (1,345) 0.2 2.8 57.3 97.9 100.0 -
exico (974) 0.5 3.9 74.6 99.2 99.9 -
ll regions
Methicillin- 0.2 3.3 77.3 99.1 >99.9 100.0MRSA
(2479)
0.1 1.5 41.6 97.5 100.0 -
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Conclusion: Signiﬁcant resistance variations among SA
nd several classes of antimicrobial agents were observed
n LA countries. Daptomycin showed consistent potency
gainst recent clinical isolates of SA collected in LA medical
enters, including MDR strains. Resistance to other com-
ounds did not adversely inﬂuence daptomycin potency and
ith S rates at over 99.9% during the past ﬁve years sug-
ests that daptomycin has maintained in vitro activity in LA
ountries.
oi:10.1016/j.ijid.2010.02.1913
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n vitro activity of new compound YF-13-1 against gram-
ostive and gram-negative bacteria strains of clinical
solates in chain
. Zhang1,∗, Y. Liu2
Sichuan industral Institue antibiotics, Chengdu, Sichuan,
hina
Sichuan Industral Institute of Antibiotical, chengdu,
ichuan, China
Background: The Present study is undertaken to evaluate
nd compared the activity of the new compound YF-13-1
lone and with eight antibiotics against gram — positive and
ram — negative. Bacterial strains. The majority of bacterial
trains evaluated in this study were recent clinical isolates
btained from several hospital sources in China.
Methods: Determination of antibacterial activity in vitro:
inimum inhibitory concentrations (MICs) were determined
ccording to CLSI(formerly NCCLs guidelines using cation —
djusted Mueller-Hinton agar.) by the agar dilution method
ith a Multiple innoculator replicator (steers-folty repli-
ator) serialtwofold dilutions of the compounds will be
repared 10-fold in agar, ranged from 128 to 0.008 ug/ml (for
xtremely sensitive organisms, further dilutions).the lowest
oncentration which allowed the growth of no more than
hree colonies is considered to be the MICs.
Results: The results showed that YF-13-1 was a broad-
pectrum Antibiotics. MIC50, MIC90 values for YF-13-1 were
ach 0.25mg/L and 1mg/L against ciproﬂoxacin-susceptible
nd levoﬂoxacin- susceptible S.aureus strains. It inhib-
ted 90% tested Ciproﬂoxacin and levoﬂoxacin- resistant
. aureus strains at less than 16mg/L. MIC 90 values
gainst S. aureus MRSA, MSSA was 4mg/L, 0.25mg/L respec-
ively. YF-13-1 was more active against coagulose-negative.
taphylococci and S.epidermidis MRSE, MSSE, MIC90 were
mg/L, 8mg/L; 2mg/L and 0.25mg/L respectively. MIC90
as)4mg/L against S.pyogenes, S.pneumoniae and Entero-
occcus. MIC 90 4, 8, 0.5mg/L against Branhemella bacteria,
nﬂuengae and Gonococcal respectively. Whereas, the YF-
s
a
c
dternational Congress on Infectious Diseases (ICID) Abstracts
3-1 MIC range for E.coli, K. peumoniae, Proteus, Serratia
arcescens, E. aerogenes and cloacae were 0.008- 32mg/L.
IC50, MIC90 was 2mg/L and 8mg/L against P. aerogenes
espectively, But, it less active against acinetobacter bau-
annii, MIC50, MIC90 was 8mg/L, 128mg/L respectively.
Conclusion: The results showed that YF-13-1 was a broad-
pectrum Antibiotics.
oi:10.1016/j.ijid.2010.02.1914
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0-hydroxy-2-decenoic acid induce dispersion of Strepto-
occus mutans bioﬁlms
. Shoae Hassani1,∗, N. Ordouzadeh2
Islamic Azad University (IAU), Fars Science & Research,
ran, Islamic Republic of
Azad University, Fars, Iran, Islamic Republic of
Background: Hydroxy decenoic acid is a bioactive com-
onent of royal jelly that occupies its 10% of the total
eight. Bioﬁlms progress through multiple developmental
tages, beginning with reversible attachment to a surface,
ollowed by irreversible attachment and development of
icrocolonies, when dispersion occurs, releasing cells into
he bulk liquid. Colonization and Bioﬁlm formation of Strep-
ococcus mutans is the causative agent of dental plaques
nd subsequently dental caries.
Methods: 10-hydroxy decenoic acid was puriﬁed by
eans of HPLC. Glass slides were used for bioﬁlm for-
ation in treated media with each slide in a total area
f 6 cm2. Microtiter plate dispersion bioassays were used
o test various preparations for their ability to exoge-
ously induce Streptococcus mutans ATCC 25175 bioﬁlm
ispersion.
Results: Hydroxy decenoic acid is capable of inducing the
ispersion of established bioﬁlms and of inhibiting bioﬁlm
evelopment. When added exogenously to Streptococcus
utans bioﬁlms at a native concentration of 2.5 nM, it was
hown to induce the dispersion of bioﬁlm microcolonies.
hese dispersion events were observed to originate at the
enter of microcolonies near the substratum, but only within
icrocolonies that had attained a minimum diameter of 40
nd a minimum thickness of 10m.
Conclusion: Active at nanomolar concentrations,
ydroxy-2-decenoic acid appears to be functionally and
tructurally related to the class of short-chain fatty acid
ignaling molecules such as diffusible signal factor, which
ct as cell-to-cell communication molecules in bacterial
olonies.
oi:10.1016/j.ijid.2010.02.1915
